ARTICLE | Company News
Vertex's Agenerase approved in Europe
October 23, 2000 7:00 AM UTC
The European Commission granted marketing approval for VRTX's Agenerase amprenavir protease inhibitor to treat HIV infection/AIDS in combination with other antiretrovirals in protease inhibitor-experi...